Babylon Reaches $4.2 Billion Deal With Ex-Groupon CEO’s SPAC
(Bloomberg) -- Babylon Holdings Ltd., the medical startup that connects patients and doctors via an app, is going public via a merger with a blank-check company run by former Groupon Inc. executives.
Alkuri Global Acquisition Corp. is raising about $230 million from investors including Palantir Technologies Inc. in a private placement to support the deal, according to a statement Thursday. The transaction implies an equity value of about $4.2 billion for Babylon and is expected to close in the second half of 2021.
New backers including Swedish pension fund AMF Pensionsforsakring, health care-focused investor Sectoral Asset Management and Scandinavian asset manager Swedbank Robur are participating in the private placement. The deal is expected to deliver as much as to $575 million of gross proceeds to Babylon, according to the statement.
“We think we have an opportunity to build one of the world's largest companies in one of the world's largest sectors,” Babylon Chief Executive Officer Ali Parsa said in an interview. “Six months ago when we started being bombarded by SPACs, it was the best thing since sliced bread and today it's just not the flavor of the month. For us they still remain a very efficient, fast way of going public and achieving the results – of going public.”
Bloomberg News reported last week that Babylon was nearing an agreement with Alkuri. Babylon will trade on the Nasdaq under the symbol “BBLN” after the deal closes, Thursday's statement shows.
Founded in 2013, Babylon's app lets users schedule a video chat with a doctor, check symptoms or book time with specialists, such as therapists. It can be used to seek advice and treatment for conditions ranging from hair loss to chronic kidney disease, according to its website.
The U.K.'s National Health Service lets patients choose Babylon's “GP in Hand” mobile consultation service as their official primary care provider, and the startup last year said its artificial intelligence software, in tests, can assess common conditions more accurately than human doctors.
However, the startup's patient-facing AI symptom checker has been the target of criticism that it's capable of missing serious health problems.
In 2019, Babylon raised $550 million in a funding round valuing the business at more than $2 billion. Its backers include Saudi Arabia's Public Investment Fund, Munich Re Ventures, Kinnevik AB, NNS Holding, the family office of Nassef Sawiris, and Vostok New Ventures.
Kinnevik said Thursday it would invest $5 million as part of Babylon's private placement, bringing its ownership after the transaction closes to 13%. Babylon also confirmed it would acquire the remaining shares of consumer health engagement startup Higi, which it invested in as recently as May last year.
Parsa said that while Babylon's current growth expectations don't factor in future acquisitions, the company could look for additional growth through deals that give it access to technology, distribution or more customers. The company expects to see “significant growth” in 2022 from contracts that it's agreeing to currently, Parsa said.
Alkuri is a special purpose acquisition company led by Groupon's ex-chief executive officer Rich Williams and former chief operating officer Steve Krenzer, who left those roles last year after turnaround plans for the online discount provider faltered. Sultan Almaadeed, a former executive at the Qatar Investment Authority, is Alkuri's chairman.
“We see this as really the future of what health care can be especially in a health-care market that's broken and embarrassingly so,” Williams said in an interview. “Our view is that it's a space that's ripe for disruption. For too long we've tolerated this idea that quality and affordability can't be balanced in health care. With Babylon we see opportunity to partner with a team that we think can deliver that balance.”
Ardea Partners LP and Citigroup Inc. advised Babylon on the deal, while Alkuri worked with Jefferies Financial Group Inc., according to Thursday's statement. Jefferies, Citigroup and Pareto Securities AB acted as placement agents for the private investment in public equity, or PIPE, offering.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.